United Health Products (UEEC) Cash from Financing Activities (2010 - 2026)
United Health Products (UEEC) posted quarterly Cash from Financing Activities of $20119.0 for Q1 2026, down 81.71% year-over-year from $110000.0 in Q1 2025, and down 96.65% quarter-over-quarter from $600000.0 in Q4 2025.
United Health Products (UEEC) Cash from Financing Activities (2010 - 2026) Analysis & Trends
United Health Products (UEEC) has reported Cash from Financing Activities for 17 consecutive years, with $20119.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 81.71% year-over-year to $20119.0; the TTM figure through Mar 2026 stood at $993427.0 (up 0.66% YoY), while the FY2025 annual figure was $1.1 million, down 14.58% from the prior year.
- Cash from Financing Activities fell to $20119.0 in Q1 2026 per UEEC's latest filing, from $600000.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $600000.0 in Q4 2025 and bottomed at $20119.0 in Q1 2026.
- Historically, Cash from Financing Activities has averaged $312290.7 across 5 years, with a median of $247372.0 in 2022.
- Annual changes were most pronounced in 2023 — Cash from Financing Activities jumped 490.2% — and 2026, when it plunged 81.71%.
- United Health Products' Cash from Financing Activities stood at $135115.0 in 2022, then soared by 342.5% to $597881.0 in 2023, then slumped by 48.73% to $306538.0 in 2024, then soared by 95.73% to $600000.0 in 2025, then slumped by 96.65% to $20119.0 in 2026.
- Business Quant data shows UEEC's Cash from Financing Activities at $20119.0 in Q1 2026, $600000.0 in Q4 2025, and $193308.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -287.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -577.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -510.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -263.16 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -159.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -300.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -75.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -31.00 Mn |
| 10 | United Health Products | 9.79 Mn | 9.77 Mn | - | 161,479.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20,119.00 |
| Mar 31, 2026 | 20,119.00 |
| Dec 31, 2025 | 600,000.00 |
| Dec 31, 2025 | 600,000.00 |
| Sep 30, 2025 | 193,308.00 |
| Sep 30, 2025 | 193,308.00 |
| Jun 30, 2025 | 180,000.00 |
| Jun 30, 2025 | 180,000.00 |
| Mar 31, 2025 | 110,000.00 |
| Mar 31, 2025 | 110,000.00 |
| Dec 31, 2024 | 306,538.00 |
| Dec 31, 2024 | 306,538.00 |
| Sep 30, 2024 | 344,826.00 |
| Sep 30, 2024 | 344,826.00 |
| Jun 30, 2024 | 225,590.00 |
| Jun 30, 2024 | 225,590.00 |
| Mar 31, 2024 | 391,225.00 |
| Mar 31, 2024 | 391,225.00 |
| Dec 31, 2023 | 597,881.00 |
| Dec 31, 2023 | 597,881.00 |